50 Years of Myofibroblasts: How the Myofibroblast Concept Evolved

Area of Science:

• Cell Biology
• Tissue Engineering
• Biomedical Research

Background:

• Myofibroblasts are central to wound contraction and fibrotic diseases.
• Discovered 50 years ago, they possess contractile microfilaments similar to smooth muscle.
• Neo-expression of alpha-smooth muscle actin (α-SMA) is a key marker.

Purpose of the Study:

• To elucidate the mechanisms of myofibroblast formation and function.
• To provide essential experimental tools and animal models for research.
• To facilitate understanding for therapeutic development against fibrosis and scarring.

Main Methods:

• Characterization of myofibroblast contractile properties via tissue strip contraction assays.
• In vitro cell culture studies to assess myofibroblast behavior.
• Development and utilization of specialized animal models and experimental protocols.

Main Results:

• Demonstrated contractile function of myofibroblasts in granulation tissue and cell culture.
• Established α-SMA as a primary marker for myofibroblast identification.
• Validated α-SMA as a drug target for reducing tissue contractures.

Conclusions:

• Myofibroblast contractile function, marked by α-SMA, is critical in wound healing and fibrosis.
• Targeting myofibroblast pathways offers therapeutic strategies for fibrotic conditions.
• Availability of expert-developed tools and models advances myofibroblast research.